- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:18 | RBC Capital downgrades Chimera Investment stock rating to Sector Perform | ||
| 14:18 | Mizuho raises Erasca stock price target to $5 on RAS space optimism | ||
| 14:18 | Life360 stock rating reiterated at Hold by Stifel amid adtech acquisition | ||
| 14:18 | Raymond James upgrades Enerflex stock to Strong Buy on operational turnaround | ||
| 14:18 | Circle Internet Group stock gains as Baird reiterates Outperform on Bybit deal | ||
| 14:06 | Antero Midstream launches $500 million senior notes offering | ||
| 14:06 | ZenaTech acquires UK's Casado Design to expand drone services | ||
| 14:06 | Johnson & Johnson's teclistamab-daratumumab combo shows strong results in multiple myeloma trial | ||
| 14:06 | Lunai bioworks identifies three parkinsons disease subtypes | ||
| 14:06 | Elanco outlines growth plan, restructuring in investor day update | ||
| 14:06 | Lilly's Jaypirca reduces progression risk by 80% in untreated CLL | ||
| 14:06 | Long Path Partners increases support for Idox acquisition | ||
| 14:06 | Sabesp Q3 2025 slides: EBITDA jumps 15% despite flat revenue, Capex accelerates | ||
| 14:06 | IBM stock price target raised to $325 from $295 at Stifel on Confluent deal | ||
| 14:06 | Agios Pharma stock awaits FDA decision on Pyrukynd as PDUFA date passes | ||
| 14:06 | Marvell stock rating reiterated at Overweight by JPMorgan on strong AI outlook | ||
| 14:06 | Geron stock rating reiterated as Neutral by H.C. Wainwright | ||
| 14:06 | H.C. Wainwright raises Rapport Therapeutics stock price target to $40 on strong seizure drug data | ||
| 14:06 | Syndax stock maintains Buy rating as Revuforj shows real-world success | ||
| 14:06 | Synopsys stock rating reiterated at Buy by Rosenblatt ahead of Q4 results | ||
| 14:06 | Mirum Pharmaceuticals stock rises as H.C. Wainwright reiterates Buy rating | ||
| 14:06 | Stifel maintains Hold rating on Yum! Brands stock amid Pizza Hut review | ||
| 14:06 | H.C. Wainwright reiterates Buy rating on Disc Medicine stock | ||
| 13:42 | MarketAxess announces $400 million share buyback, medium-term targets | ||
| 13:42 | Cronos to acquire Dutch cannabis firm CanAdelaar for $67 million |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .